
Carol M. Koslow
Examiner (ID: 12920, Phone: (571)272-1371 , Office: P/1734 )
| Most Active Art Unit | 1734 |
| Art Unit(s) | 1734, 1754, 1793, 1755, 1108 |
| Total Applications | 5011 |
| Issued Applications | 4022 |
| Pending Applications | 258 |
| Abandoned Applications | 784 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10975360
[patent_doc_number] => 20140378395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Peptides for the Treatment of Hearing'
[patent_app_type] => utility
[patent_app_number] => 14/047802
[patent_app_country] => US
[patent_app_date] => 2013-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 50225
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14047802
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/047802 | Peptides for the Treatment of Hearing | Oct 6, 2013 | Abandoned |
Array
(
[id] => 10769043
[patent_doc_number] => 20160115199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'Cell Penetrating Peptides for Intracellular Delivery of Molecules'
[patent_app_type] => utility
[patent_app_number] => 14/433578
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6251
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433578
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/433578 | Cell penetrating peptides for intracellular delivery of molecules | Oct 3, 2013 | Issued |
Array
(
[id] => 10389773
[patent_doc_number] => 20150274780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'CONFORMATIONALLY-CONSTRAINED KINKED ENDOSOMAL-DISRUPTING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/438194
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13580
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438194
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/438194 | Conformationally-constrained kinked endosomal-disrupting peptides | Oct 2, 2013 | Issued |
Array
(
[id] => 9211590
[patent_doc_number] => 20140010767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'METHODS AND MATERIALS FOR PROVIDING TEETH WITH A WHITE APPEARANCE'
[patent_app_type] => utility
[patent_app_number] => 14/029115
[patent_app_country] => US
[patent_app_date] => 2013-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9076
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14029115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/029115 | Methods and materials for providing teeth with a white appearance | Sep 16, 2013 | Issued |
Array
(
[id] => 9641943
[patent_doc_number] => 20140220054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'WT1 HLA CLASS II-BINDING PEPTIDES AND COMPOSITIONS AND METHODS COMPRISING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/028329
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24737
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/028329 | WT1 HLA class II—binding peptides and compositions and methods comprising same | Sep 15, 2013 | Issued |
Array
(
[id] => 10325737
[patent_doc_number] => 20150210741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'JAGARICIN DERIVATIVES AND THEIR USE AS FUNGICIDE OR ANTITUMOR AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/425010
[patent_app_country] => US
[patent_app_date] => 2013-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9140
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14425010
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/425010 | JAGARICIN DERIVATIVES AND THEIR USE AS FUNGICIDE OR ANTITUMOR AGENT | Aug 21, 2013 | Abandoned |
Array
(
[id] => 10347505
[patent_doc_number] => 20150232511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'METHOD FOR PRODUCING A COMPOSITION FOR TREATING A TOOTH LESION'
[patent_app_type] => utility
[patent_app_number] => 14/421666
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9750
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421666
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/421666 | Method for producing a composition for treating a tooth lesion | Aug 13, 2013 | Issued |
Array
(
[id] => 10339163
[patent_doc_number] => 20150224168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'COMBINATIONS WITH A BACKBONE-CYCLIZED PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 14/419992
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9176
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419992
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419992 | Combinations with a backbone-cyclized peptide | Aug 6, 2013 | Issued |
Array
(
[id] => 11907080
[patent_doc_number] => 09775877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Combinations with a backbone-cyclized peptide'
[patent_app_type] => utility
[patent_app_number] => 14/419986
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4909
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419986
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419986 | Combinations with a backbone-cyclized peptide | Aug 6, 2013 | Issued |
Array
(
[id] => 9162042
[patent_doc_number] => 20130310319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'FAST DISSOLVING PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/952084
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11370
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952084
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/952084 | Fast dissolving pharmaceutical composition | Jul 25, 2013 | Issued |
Array
(
[id] => 10341736
[patent_doc_number] => 20150226740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'METHOD FOR IDENTIFYING NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/421310
[patent_app_country] => US
[patent_app_date] => 2013-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30173
[patent_no_of_claims] => 180
[patent_no_of_ind_claims] => 105
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421310
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/421310 | Method for identifying novel minor histocompatibility antigens | Jul 24, 2013 | Issued |
Array
(
[id] => 11575942
[patent_doc_number] => 09631190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-25
[patent_title] => 'Cell attachment coatings and methods using phosphorous-containing photoreagent'
[patent_app_type] => utility
[patent_app_number] => 13/930512
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11394
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930512
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/930512 | Cell attachment coatings and methods using phosphorous-containing photoreagent | Jun 27, 2013 | Issued |
Array
(
[id] => 10317247
[patent_doc_number] => 20150202250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'ANTICANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/408780
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 29131
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408780
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/408780 | ANTICANCER TREATMENT | Jun 24, 2013 | Abandoned |
Array
(
[id] => 10202605
[patent_doc_number] => 20150087593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'COAGULATION FACTOR VIII WITH REDUCED IMMUNOGENICITY'
[patent_app_type] => utility
[patent_app_number] => 14/402922
[patent_app_country] => US
[patent_app_date] => 2013-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8828
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402922
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402922 | Coagulation factor VIII with reduced immunogenicity | May 20, 2013 | Issued |
Array
(
[id] => 9691246
[patent_doc_number] => 08821836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-02
[patent_title] => 'SPARC binding peptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/896973
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15643
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896973
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/896973 | SPARC binding peptides and uses thereof | May 16, 2013 | Issued |
Array
(
[id] => 11574698
[patent_doc_number] => 09629939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-25
[patent_title] => 'Collagenous foam materials'
[patent_app_type] => utility
[patent_app_number] => 14/403396
[patent_app_country] => US
[patent_app_date] => 2013-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5283
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403396
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403396 | Collagenous foam materials | May 15, 2013 | Issued |
Array
(
[id] => 10256331
[patent_doc_number] => 20150141329
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2015-05-21
[patent_title] => 'NEURTURIN MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 13/846281
[patent_app_country] => US
[patent_app_date] => 2013-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29974
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/846281 | Neurturin molecules | Mar 17, 2013 | Issued |
Array
(
[id] => 10256331
[patent_doc_number] => 20150141329
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2015-05-21
[patent_title] => 'NEURTURIN MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 13/846281
[patent_app_country] => US
[patent_app_date] => 2013-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29974
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/846281 | Neurturin molecules | Mar 17, 2013 | Issued |
Array
(
[id] => 9844247
[patent_doc_number] => 08946163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Cross-linked collagen comprising metallic anticancer agents'
[patent_app_type] => utility
[patent_app_number] => 13/815834
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15454
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815834
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/815834 | Cross-linked collagen comprising metallic anticancer agents | Mar 14, 2013 | Issued |
Array
(
[id] => 10202601
[patent_doc_number] => 20150087590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'DIASPIRIN CROSSLINKED PEGYLATED HEMOGLOBIN'
[patent_app_type] => utility
[patent_app_number] => 14/388956
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10633
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388956
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388956 | Diaspirin crosslinked pegylated hemoglobin | Mar 14, 2013 | Issued |